Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23499947 | 0.91 | CNR2 (0.59) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL11574652 | 0.89 | ALDH1A1 (0.54) | CTSDCYP2C19CYP2C9CNR2MAPT | |
| SCHEMBL7500668 | 0.88 | CTSD (0.52) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL979842 | 0.86 | CA12 (0.58) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL5403782 | 0.85 | CA12 (0.56) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL24954211 | 0.84 | ABCG2 (0.57) | CTSDCYP1A2CYP2C19CYP3A4CNR2 | |
| SCHEMBL29625745 | 0.84 | ABCG2 (0.57) | CTSDCYP1A2CYP2C19CYP3A4CNR2 | |
| SCHEMBL3357585 | 0.83 | NCEH1 (0.65) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL30676839 | 0.83 | NCEH1 (0.65) | CTSDCYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL18288073 | 0.83 | ALDH1A1 (0.58) | CTSDKDM4EHSD17B10LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | THE UNIVERSITY OF CHICAGO (US) | 2024-07-23 | — | — | US | disclosed |
| US-20210053042-A1 | STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS | NATIONAL SCIENCE FOUNDATION | 2021-02-25 | — | — | US | disclosed |
| US-20210053042-A1 | STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS | NATIONAL SCIENCE FOUNDATION | 2021-02-25 | — | — | US | disclosed |
| US-6348631-B1 | REACTING AROMATIC COMPOUND WITH ACYLATING OR SULFONYLATING AGENT IN PRESENCE OF FRIEDEL-CRAFTS CATALYST, WHEREIN ACYLATION OR SULFONYLATION REACTION IS CARRIED OUT IN LIQUID PHASE UNDER MICROWAVE IRRADIATION | RHODIA CHIMIE (FR) | 2002-02-19 | — | — | US | disclosed |
| EP-1019351-A1 | METHOD FOR ACYLATION OR SULPHONATION OF AN AROMATIC COMPOUND | RHODIA CHIMIE (FR) | 2000-07-19 | — | — | EP | disclosed |
| CN-1249737-A | Method for acylation or sulphonation of aromatic compound | RHODIA CHIMIE SA (FR) | 2000-04-05 | — | — | CN | disclosed |
| WO-1998040339-A1 | METHOD FOR ACYLATION OR SULPHONATION OF AN AROMATIC COMPOUND | RHODIA CHIMIE (FR) | 1998-09-17 | — | — | WO | disclosed |
| EP-0426846-A1 | FLUORINATED-AROMATIC SULFONIC ACID CATALYST, PROCESS FOR ITS PRODUCTION, AND ITS USE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | CD69, TECR, MCM4 | CTSD 1986/4885CYP1A2 1493/4885CYP2C19 2057/4885 |
| US-20210053042-A1 | STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS | CD69, TECR, MCM4 | CTSD 1986/4885CYP1A2 1493/4885CYP2C19 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.